Advanced TB Topics: Next-Generation Diagnostics

[webinar]

Date: November 07, 2022

Time: 10:00 - 11:00am Pacific Time. (All of our virtual trainings are in Pacific Time. If you are unsure about the time zone differences, please use the Time Converter)

Cost: There is no fee for this training.

Credit: This training is approved for up to 1.00 continuing education hour (see below). Certificates will be available approximately 12 weeks after the training to participants who complete the entire training and evaluation.

Target Audience: This training is intended for physicians, nurses, and other health professionals who diagnose and treat patients with TB.

Description: This training will provide an overview of exciting diagnostic test options for TB, both new and on the horizon.

Training Objectives:

By the end of the training, participants will be able to:

• Explain current recommendations and available tools in the United States and globally to optimize rapid diagnosis of TB and reduce disease transmission
• Describe the progress and advances in development of novel diagnostics for pulmonary TB (molecular testing & urine LAM tests) to prepare learner with knowledge for anticipated future application
• Describe the benefits of the upcoming transition of the Molecular Detection of Drug Resistance (MDDR) Service offered by the CDC TB Reference Laboratory towards a targeted next generation sequencing assay

Webinar Format: lecture and Q&A

.

Presenters:

Adithya Cattamanchi, MD, MAS
Professor of Medicine
University of California, San Francisco
San Francisco, CA
 

Atanaska Marinova-Petkova, DVM, MS, PhD
Team Lead, Reference Laboratory
Laboratory Branch
Division of Tuberculosis Elimination
Centers for Disease Control and Prevention
Atlanta, GA

Moderator:

Lisa Chen, MD
Medical Director/TB COE Principal Investigator
Curry International Tuberculosis Center
University of California, San Francisco
Berkeley, CA


The Curry International Tuberculosis Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This training is approved for up to 1.00 continuing education hour.

The Curry International Tuberculosis Center designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses, Provider Number CEP 12308. This training is approved for up to 1.00 continuing education hour. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the training, or leave the training early. Therefore, partial credit will not be awarded.
 

The Curry International Tuberculosis Center is designated as a Tuberculosis Center of Excellence for Training, Education, and Medical Consultation (TB COE) via a funded cooperative agreement with the Centers for Disease Control and Prevention. The Curry International Tuberculosis Center prioritizes learners from the western region of the United States which consists of seventeen jurisdictions: Alaska, Arizona, California (including Los Angeles, San Diego, and San Francisco), Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming, and the U.S. Pacific Island Territories.

.